MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
3.980
-0.020
-0.50%
After Hours: 3.980 0 0.00% 16:10 12/30 EST
OPEN
3.980
PREV CLOSE
4.000
HIGH
4.030
LOW
3.900
VOLUME
3.29M
TURNOVER
--
52 WEEK HIGH
6.75
52 WEEK LOW
1.150
MARKET CAP
1.45B
P/E (TTM)
-4.8918
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATAI last week (1222-1226)?
Weekly Report · 1d ago
Ametek, MindMed, Atai, Prime and KB Home Trending
TipRanks · 3d ago
The 1 Riskiest Investment That Paid Off in 2025
Barchart · 5d ago
Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal
TipRanks · 12/23 17:05
Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls
TipRanks · 12/23 14:35
ATAI Life Sciences Initiated at Buy by Jones Trading
Dow Jones · 12/23 14:09
ATAI Life Sciences Price Target Announced at $16.00/Share by Jones Trading
Dow Jones · 12/23 14:09
Jones Trading Initiates Coverage On Atai Beckley with Buy Rating, Announces Price Target of $16
Benzinga · 12/23 13:59
More
About ATAI
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Webull offers Atai Beckley NV stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.